← Leaderboards
William R Sellers
Dana-Farber Cancer Institute
$5,772,651
Attributed
$6,939,941
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,893,502 · 7
By mechanism
P50$5,953,561 · 2
R01$5,212,526 · 3
P01$1,727,415 · 2
Top collaborators
- Nabeel Bardeesy5 shared
- Sandra W Ryeom2 shared
- Andrew James Aguirre1 shared
Most similar at Dana-Farber Cancer Institute
Same institution · by research overlap
- Levi Alexander Garraway$17,056,330
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMalignant NeoplasmsClinical TrialsPathway InteractionsGenesResponseAndrogen ReceptorSignal TransductionGrantPhosphorylationGeneticProgramsGenomicsMutationInhibitor/AntagonistMediatingGene MutationIn VivoCancer PatientIn VitroMutantNew Therapeutic TargetHuman TissueCollaborations
Grant awards (24)
Targeting FGFR Alterations in Gastroesophageal Cancer$680,532
R01 · FY2025 · CA
The function of the PRMT5 methylosome in MTAP deleted cancers$472,119
R01 · FY2025 · CA · contact PI
Targeting FGFR Alterations in Gastroesophageal Cancer$716,314
R01 · FY2024 · CA
Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer$2,248,301
P50 · FY2023 · CA · contact PI
The function of the PRMT5 methylosome in MTAP deleted cancers$380,377
R01 · FY2023 · CA · contact PI
Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer$2,157,311
P50 · FY2022 · CA · contact PI
The function of the PRMT5 methylosome in MTAP deleted cancers$380,377
R01 · FY2022 · CA · contact PI
Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer$1,547,949
P50 · FY2021 · CA · contact PI
The function of the PRMT5 methylosome in MTAP deleted cancers$388,141
R01 · FY2021 · CA · contact PI
The function of the PRMT5 methylosome in MTAP deleted cancers$435,438
R01 · FY2020 · CA · contact PI
The function of the PRMT5 methylosome in MTAP deleted cancers$432,036
R01 · FY2019 · CA · contact PI
The Role of AKT in Prostate Cancer$323,496
P01 · FY2011 · CA · contact PI
The Role of AKT in Prostate Cancer$333,721
P01 · FY2010 · CA · contact PI
The Role of AKT in Prostate Cancer$327,393
P01 · FY2009 · CA · contact PI
The Role of AKT in Prostate Cancer$318,864
P01 · FY2008 · CA · contact PI
The Role of AKT in Prostate Cancer$320,264
P01 · FY2007 · CA · contact PI
FUNCTIONAL ANALYSIS OF THE PTEN TUMOR SUPPRESSOR PROTEIN$264,884
R01 · FY2004 · CA
FUNCTIONAL ANALYSIS OF THE PTEN TUMOR SUPPRESSOR PROTEIN$264,884
R01 · FY2003 · CA
FUNCTIONAL ANALYSIS OF THE PTEN TUMOR SUPPRESSOR PROTEIN$265,136
R01 · FY2002 · CA
PI3K pathway in prostate epithelial transformation$103,677
P01 · FY2002 · CA
Single nucleotide repeat polymorphism analysis of recurrent prostate cancer$0
P50 · FY2002 · CA
FUNCTIONAL ANALYSIS OF THE PTEN TUMOR SUPPRESSOR PROTEIN$265,892
R01 · FY2001 · CA
PI3K pathway in prostate epithelial transformation$0
P01 · FY2001 · CA
FUNCTIONAL ANALYSIS OF THE PTEN TUMOR SUPPRESSOR PROTEIN$266,396
R01 · FY2000 · CA